Animal models and therapeutic molecular targets of cancer: utility and limitations

References

• Hanahan D Weinberg RA Hallmarks of cancer: the next generation Cell 2011 144 5 646 674 21376230
   PubMed Web of Science ®Google Scholar
• American Cancer Society Cancer facts and figures 2014 Available from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf Accessed April 2, 2014
   Google Scholar
• Masters JR HeLa cells 50 years on: the good, the bad and the ugly Nat Rev Cancer 2002 2 4 315 319 12001993
   PubMed Web of Science ®Google Scholar
• Harris SA Enger RJ Riggs BL Spelsberg TC Development and characterization of a conditionally immortalized human fetal osteoblastic cell line J Bone Miner Res 1995 10 2 178 186 7754797
   PubMed Web of Science ®Google Scholar
• Fichorova RN Rheinwald JG Anderson DJ Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins Biol Reprod 1997 57 4 847 855 9314589
   PubMed Web of Science ®Google Scholar
• Welte Y Davies C Schafer R Regenbrecht CR Patient derived cell culture and isolation of CD133(+) putative cancer stem cells from melanoma J Vis Exp 2013 73 e50200 23525090
   PubMed Web of Science ®Google Scholar
• Rathore K Alexander M Cekanova M Piroxicam inhibits masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro Transl Res 2 21 2014 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Cekanova M Masi T Plummer HK3rd Majidi M Fedorocko P Schuller HM Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas Anticancer Drugs 2006 17 7 771 781 16926627
   PubMed Web of Science ®Google Scholar
• Wang C Tang Z Zhao Y Yao R Li L Sun W Three-dimensional in vitro cancer models: a short review Biofabrication 2014 6 2 022001 24727833
   PubMed Web of Science ®Google Scholar
• Knapp DW Waters DJ Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans Mol Med Today 1997 3 1 8 11 9021736
   PubMedGoogle Scholar
• Spugnini EP Porrello A Citro G Baldi A COX-2 overexpression in canine tumors: potential therapeutic targets in oncology Histol Histopathol 2005 20 4 1309 1312 16136511
   PubMed Web of Science ®Google Scholar
• MacEwen EG Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment Cancer Metastasis Rev 1990 9 2 125 136 2253312
   PubMed Web of Science ®Google Scholar
• Cheon DJ Orsulic S Mouse models of cancer Annu Rev Pathol 2011 6 95 119 20936938
   PubMed Web of Science ®Google Scholar
• Ruggeri BA Camp F Miknyoczki S Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery Biochem Pharmacol 2014 87 1 150 161 23817077
   PubMed Web of Science ®Google Scholar
• Huynh AS Abrahams DF Torres MS Baldwin MK Gillies RJ Morse DL Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells PLoS One 2011 6 5 e20330 21647423
   PubMed Web of Science ®Google Scholar
• Bibby MC Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages Eur J Cancer 2004 40 6 852 857 15120041
   PubMed Web of Science ®Google Scholar
• Morton CL Houghton PJ Establishment of human tumor xenografts in immunodeficient mice Nat Protoc 2007 2 2 247 250 17406581
   PubMed Web of Science ®Google Scholar
• Sharpless NE Depinho RA The mighty mouse: genetically engineered mouse models in cancer drug development Nat Rev Drug Discov 2006 5 9 741 754 16915232
   PubMed Web of Science ®Google Scholar
• Cekanova M Uddin MJ Bartges JW Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo Cancer Prev Res (Phila) 2013 6 5 466 476 23531445
   PubMed Web of Science ®Google Scholar
• Frese KK Tuveson DA Maximizing mouse cancer models Nat Rev Cancer 2007 7 9 645 658 17687385
   PubMed Web of Science ®Google Scholar
• Zupancic D Kreft ME Romih R Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models Protoplasma 2014 251 1 49 59 23828036
   PubMed Web of Science ®Google Scholar
• Ogawa K John MS De Oliveira ML Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice Toxicol Pathol 1999 27 6 645 651 10588545
   PubMed Web of Science ®Google Scholar
• Becci PJ Thompson HJ Strum JM Brown CC Sporn MB Moon RC N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids Cancer Res 1981 41 3 927 932 7459879
   PubMed Web of Science ®Google Scholar
• McCormick DL Ronan SS Becci PJ Moon RC Influence of total dose and dose schedule on induction of urinary bladder cancer in the mouse by N-butyl-N-(4-hydroxybutyl)nitrosamine Carcinogenesis 1981 2 3 251 254 7273310
   PubMed Web of Science ®Google Scholar
• Schuller HM Cekanova M NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways Lung Cancer 2005 49 1 35 45 15949588
   PubMed Web of Science ®Google Scholar
• Schuller HM Kabalka G Smith G Mereddy A Akula M Cekanova M Detection of overexpressed COX-2 in precancerous lesions of hamster pancreas and lungs by molecular imaging: implications for early diagnosis and prevention ChemMedChem 2006 1 6 603 610 16892400
   PubMed Web of Science ®Google Scholar
• Russell WL Kelly EM Hunsicker PR Bangham JW Maddux SC Phipps EL Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse Proc Natl Acad Sci U S A 1979 76 11 5818 5819 293686
   PubMed Web of Science ®Google Scholar
• Neufert C Becker C Neurath MF An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression Nat Protoc 2007 2 8 1998 2004 17703211
   PubMed Web of Science ®Google Scholar
• Tanaka T Kohno H Suzuki R Yamada Y Sugie S Mori H A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate Cancer Sci 2003 94 11 965 973 14611673
   PubMed Web of Science ®Google Scholar
• Denissenko MF Pao A Tang M Pfeifer GP Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 Science 1996 274 5286 430 432 8832894
   PubMed Web of Science ®Google Scholar
• Cekanova M Lee SH Donnell RL Nonsteroidal anti- inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice Cancer Prev Res (Phila) 2009 2 5 450 458 19401523
   PubMed Web of Science ®Google Scholar
• Barrett JC Lamb PW Wiseman RW Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers Environ Health Perspect 1989 81 81 89 2667990
   PubMed Web of Science ®Google Scholar
• Singh M Johnson L Using genetically engineered mouse models of cancer to aid drug development: an industry perspective Clin Cancer Res 2006 12 18 5312 5328 17000664
   PubMed Web of Science ®Google Scholar
• Sauer B Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae Mol Cell Biol 1987 7 6 2087 2096 3037344
   PubMed Web of Science ®Google Scholar
• Gossen M Bujard H Tight control of gene expression in mammalian cells by tetracycline-responsive promoters Proc Natl Acad Sci U S A 1992 89 12 5547 5551 1319065
   PubMed Web of Science ®Google Scholar
• Schlake T Bode J Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci Biochemistry 1994 33 43 12746 12751 7947678
   PubMed Web of Science ®Google Scholar
• Adams JM Cory S Transgenic models of tumor development Science 1991 254 5035 1161 1167 1957168
   PubMed Web of Science ®Google Scholar
• Dickins RA McJunkin K Hernando E Tissue-specific and reversible RNA interference in transgenic mice Nat Genet 2007 39 7 914 921 17572676
   PubMed Web of Science ®Google Scholar
• Stewart TA Pattengale PK Leder P Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes Cell 1984 38 3 627 637 6488314
   PubMed Web of Science ®Google Scholar
• Jacks T Fazeli A Schmitt EM Bronson RT Goodell MA Weinberg RA Effects of an Rb mutation in the mouse Nature 1992 359 6393 295 300 1406933
   PubMed Web of Science ®Google Scholar
• Fodde R Edelmann W Yang K A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors Proc Natl Acad Sci U S A 1994 91 19 8969 8973 8090754
   PubMed Web of Science ®Google Scholar
• Yamaguchi K Cekanova M McEntee MF Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways Mol Cancer Ther 2008 7 9 2779 2787 18790758
   PubMed Web of Science ®Google Scholar
• Hung KE Maricevich MA Richard LG Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment Proc Natl Acad Sci U S A 2010 107 4 1565 1570 20080688
   PubMed Web of Science ®Google Scholar
• Coffee EM Faber AC Roper J Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer Clin Cancer Res 2013 19 10 2688 2698 23549875
   PubMed Web of Science ®Google Scholar
• Martin ES Belmont PJ Sinnamon MJ Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation Clin Cancer Res 2013 19 11 2929 2940 23403635
   PubMed Web of Science ®Google Scholar
• Rowell JL McCarthy DO Alvarez CE Dog models of naturally occurring cancer Trends Mol Med 2011 17 7 380 388 21439907
   PubMed Web of Science ®Google Scholar
• Mak IW Evaniew N Ghert M Lost in translation: animal models and clinical trials in cancer treatment Am J Transl Res 2014 6 2 114 118 24489990
   PubMed Web of Science ®Google Scholar
• Teicher BA In vivo/ex vivo and in situ assays used in cancer research: a brief review Toxicol Pathol 2009 37 1 114 122 19098118
   PubMed Web of Science ®Google Scholar
• Mazcko C Comparative Oncology Program, 2012 Available from: https://ccrod.cancer.gov/confluence/display/CCRCOPWeb/Home Accessed March 28, 2014
   Google Scholar
• Paoloni M Khanna C Translation of new cancer treatments from pet dogs to humans Nat Rev Cancer 2008 8 2 147 156 18202698
   PubMed Web of Science ®Google Scholar
• Khanna C Lindblad-Toh K Vail D The dog as a cancer model Nat Biotechnol 2006 24 9 1065 1066 16964204
   PubMed Web of Science ®Google Scholar
• Lindblad-Toh K Wade CM Mikkelsen TS Genome sequence, comparative analysis and haplotype structure of the domestic dog Nature 2005 438 7069 803 819 16341006
   PubMed Web of Science ®Google Scholar
• Mendoza S Konishi T Dernell WS Withrow SJ Miller CW Status of the p53, Rb and MDM2 genes in canine osteosarcoma Anticancer Res 1998 18 6a 4449 4453 9891508
   PubMed Web of Science ®Google Scholar
• Rivera P Melin M Biagi T Mammary tumor development in dogs is associated with BRCA1 and BRCA2 Cancer Res 2009 69 22 8770 8774 19887619
   PubMed Web of Science ®Google Scholar
• Breen M Modiano JF Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans- man and his best friend share more than companionship Chromosome Res 2008 16 1 145 154 18293109
   PubMed Web of Science ®Google Scholar
• Gregory-Bryson E Bartlett E Kiupel M Hayes S Yuzbasiyan-Gurkan V Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11 BMC Cancer 2010 10 559 20950418
   PubMed Web of Science ®Google Scholar
• Porrello A Cardelli P Spugnini EP Oncology of companion animals as a model for humans. an overview of tumor histotypes J Exp Clin Cancer Res 2006 25 1 97 105 16761625
   PubMed Web of Science ®Google Scholar
• The Leukemia and Lymphoma Society Facts 2014 Available from: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/generalcancer/pdf/facts.pdf Accessed April 29, 2014
   Google Scholar
• Marconato L Gelain ME Comazzi S The dog as a possible animal model for human non-Hodgkin lymphoma: a review Hematol Oncol 2013 31 1 1 9 22674797
   PubMed Web of Science ®Google Scholar
• Withrow SJ Vail DM Page RL Withrow and MacEwen’s Small Animal Clinical Oncology 5th ed St Louis, MO, USA Elsevier 2012
   Google Scholar
• Zahm SH Blair A Pesticides and non-Hodgkin’s lymphoma Cancer Res 1992 52 Suppl 19 5485s 5488s 1394159
   PubMed Web of Science ®Google Scholar
• Hahn KA Bravo L Adams WH Frazier DL Naturally occurring tumors in dogs as comparative models for cancer therapy research In Vivo 1994 8 1 133 143 8054503
   PubMedGoogle Scholar
• Vail DM MacEwen EG Spontaneously occurring tumors of companion animals as models for human cancer Cancer Invest 2000 18 8 781 792 11107448
   PubMed Web of Science ®Google Scholar
• Hansen K Khanna C Spontaneous and genetically engineered animal models; use in preclinical cancer drug development Eur J Cancer 2004 40 6 858 880 15120042
   PubMed Web of Science ®Google Scholar
• MacEwen EG Rosenthal RC Fox LE Loar AS Kurzman ID Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma J Vet Intern Med 1992 6 4 230 234 1522554
   PubMed Web of Science ®Google Scholar
• Raju B Ibrahim SO Pathophysiology of oral cancer in experimental animal models: a review with focus on the role of sympathetic nerves J Oral Pathol Med 2011 40 1 1 9 20819130
   PubMed Web of Science ®Google Scholar
• Boria PA Murry DJ Bennett PF Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs J Am Vet Med Assoc 2004 224 3 388 394 14765798
   PubMed Web of Science ®Google Scholar
• Reif JS Bruns C Lower KS Cancer of the nasal cavity and paranasal sinuses and exposure to environmental tobacco smoke in pet dogs Am J Epidemiol 1998 147 5 488 492 9525536
   PubMed Web of Science ®Google Scholar
• Nicholls PK Klaunberg BA Moore RA Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection Virology 1999 265 2 365 374 10600607
   PubMed Web of Science ®Google Scholar
• O’Neill SH Newkirk KM Anis EA Brahmbhatt R Frank LA Kania SA Detection of human papillomavirus DNA in feline pre-malignant and invasive squamous cell carcinoma Vet Dermatol 2011 22 1 68 74 20609206
   PubMed Web of Science ®Google Scholar
• Martin CK Dirksen WP Shu ST Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma Oral Oncol 2012 48 6 491 499 22265717
   PubMed Web of Science ®Google Scholar
• DiBernardi L Dore M Davis JA Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment Prostaglandins Leuk Essent Fatty Acids 2007 76 4 245 250
   Web of Science ®Google Scholar
• Stebbins KE Morse CC Goldschmidt MH Feline oral neoplasia: a ten-year survey Vet Pathol 1989 26 2 121 128 2711569
   PubMed Web of Science ®Google Scholar
• Poirier VJ Kaser-Hotz B Vail DM Straw RC Efficacy and toxicity of an accelerated hypofractionated radiation therapy protocol in cats with oral squamous cell carcinoma Vet Radiol Ultrasound 2013 54 1 81 88 23078236
   PubMed Web of Science ®Google Scholar
• Marretta JJ Garrett LD Marretta SM Feline oral squamous cell carcinoma: an overview Available from: http://veterinarymedicine.dvm360.com/vetmed/Medicine/Feline-oral-squamous-cell-carcinoma-An-overview/ArticleStandard/Article/detail/433715 Accessed July 8, 2014
   Google Scholar
• Wypij JM A naturally occurring feline model of head and neck squamous cell carcinoma Patholog Res Int 2013 2013 502197 23970998
   PubMedGoogle Scholar
• Shapiro A Gofrit ON Pizov G Cohen JK Maier J Raman molecular imaging: a novel spectroscopic technique for diagnosis of bladder cancer in urine specimens Eur Urol 2011 59 1 106 112 21035247
   PubMed Web of Science ®Google Scholar
• Kurth KH Diagnosis and treatment of superficial transitional cell carcinoma of the bladder: facts and perspectives Eur Urol 1997 31 Suppl 1 10 19 9076481
   PubMed Web of Science ®Google Scholar
• Allard P Bernard P Fradet Y Tetu B The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index Br J Urol 1998 81 5 692 698 9634043
   PubMedGoogle Scholar
• Mohammed SI Knapp DW Bostwick DG Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder Cancer Res 1999 59 22 5647 5650 10582676
   PubMed Web of Science ®Google Scholar
• Pestili de Almeida EM Piche C Sirois J Dore M Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs J Histochem Cytochem 2001 49 7 867 875 11410611
   PubMed Web of Science ®Google Scholar
• Mutsaers AJ Widmer WR Knapp DW Canine transitional cell carcinoma J Vet Intern Med 2003 17 2 136 144 12683611
   PubMed Web of Science ®Google Scholar
• Knapp DW Richardson RC Chan TC Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder J Vet Intern Med 1994 8 4 273 278 7983623
   PubMed Web of Science ®Google Scholar
• Mutsaers AJ Widmer WR Knapp DW Canine transitional cell carcinoma J Vet Intern Med 2003 17 2 136 144 12683611
   PubMed Web of Science ®Google Scholar
• Cekanova M Uddin MJ Legendre AM Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine model J Biomed Opt 2012 17 11 116002 23117797
   PubMed Web of Science ®Google Scholar
• Brodey RS Riser WH Canine osteosarcoma – a clinicopathologic study of 194 cases Clin Orthop Relat Res 1969 62 54 64 5251443
   PubMed Web of Science ®Google Scholar
• Morello E Martano M Buracco P Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma Vet J 2011 189 3 268 277 20889358
   PubMed Web of Science ®Google Scholar
• Ru G Terracini B Glickman LT Host related risk factors for canine osteosarcoma Vet J 1998 156 1 31 39 9691849
   PubMed Web of Science ®Google Scholar
• LaRue SM Withrow SJ Powers BE Limb-sparing treatment for osteosarcoma in dogs J Am Vet Med Assoc 1989 195 12 1734 1744 2599960
   PubMed Web of Science ®Google Scholar
• Dimopoulou M Kirpensteijn J Moens H Kik M Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma Vet Surg 2008 37 5 466 471 18986314
   PubMed Web of Science ®Google Scholar
• Sonnenschein EG Glickman LT Goldschmidt MH McKee LJ Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study Am J Epidemiol 1991 133 7 694 703 2018024
   PubMed Web of Science ®Google Scholar
• American Kennel Club Canine Health Foundation Determining the best age at which to spay or neuter Available from: http://www.akcchf.org/canine-health/your-dogs-health/determining-the-best-age-at.html Accessed February 6, 2014
   Google Scholar
• Morrison WB Cancer in Dogs and Cats 1st ed Baltimore, MD, USA Williams & Wilkins 1998
   Google Scholar
• Leroy BE Northrup N Prostate cancer in dogs: comparative and clinical aspects Vet J 2009 180 2 149 162 18786842
   PubMed Web of Science ®Google Scholar
• Axiak SM Bigio A Canine prostatic carcinoma Compend Contin Educ Vet 2012 34 10 E1 E5 23532757
   PubMedGoogle Scholar
• Hifumi T Miyoshi N Kawaguchi H Nomura K Yasuda N Immunohistochemical detection of proteins associated with multidrug resistance to anti-cancer drugs in canine and feline primary pulmonary carcinoma J Vet Med Sci 2010 72 5 665 668 20086324
   PubMed Web of Science ®Google Scholar
• Coggins CR A minireview of chronic animal inhalation studies with mainstream cigarette smoke Inhal Toxicol 2002 14 10 991 1002 12396407
   PubMed Web of Science ®Google Scholar
• Shtivelman E Davies MA Hwu P Pathways and therapeutic targets in melanoma Oncotarget 2014 5 7 1701 1752 24743024
   PubMed Web of Science ®Google Scholar
• Simpson RM Bastian BC Michael HT Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma Pigment Cell Melanoma Res 2014 27 1 37 47 24128326
   PubMed Web of Science ®Google Scholar
• Bergman PJ McKnight J Novosad A Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial Clin Cancer Res 2003 9 4 1284 1290 12684396
   PubMed Web of Science ®Google Scholar
• Goldschmidt MH Pigmented lesions of the skin Clin Dermatol 1994 12 4 507 514 7866944
   PubMed Web of Science ®Google Scholar
• Modiano JF Ritt MG Wojcieszyn J The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy J Vet Intern Med 1999 13 3 163 174 10357103
   PubMed Web of Science ®Google Scholar
• Smith SH Goldschmidt MH McManus PM A comparative review of melanocytic neoplasms Vet Pathol 2002 39 6 651 678 12450197
   PubMed Web of Science ®Google Scholar
• Verhaegh W van Ooijen H Inda MA Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathways Cancer Res 2014 74 11 2936 2945 24695361
   PubMed Web of Science ®Google Scholar
• Weinberg RA The Biology of Cancer 2nd ed New York, NY, USA Garland Science, Taylor and Francis Group 2014
   Google Scholar
• Jaitak V Drug target strategies in breast cancer treatment: recent developments Anticancer Agents Med Chem 4 7 2014 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Xia W Lau YK Zhang HZ Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members Clin Cancer Res 1999 5 12 4164 4174 10632356
   PubMed Web of Science ®Google Scholar
• Dubreuil P Letard S Ciufolini M Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT PLoS One 2009 4 9 e7258 19789626
   PubMed Web of Science ®Google Scholar
• Ciruelos Gil EM Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer Cancer Treat Rev 2014 40 7 862 871 24774538
   PubMed Web of Science ®Google Scholar
• Al-Dissi AN Haines DM Singh B Kidney BA Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas Vet Pathol 2007 44 6 823 830 18039895
   PubMed Web of Science ®Google Scholar
• National Cancer Institute 2014 Available from: http://www.cancer.gov Accessed April 30, 2014
   Google Scholar
• Adams J Kauffman M Development of the proteasome inhibitor Velcade (bortezomib) Cancer Invest 2004 22 2 304 311 15199612
   PubMed Web of Science ®Google Scholar
• Chen D Frezza M Schmitt S Kanwar J Dou QP Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives Curr Cancer Drug Targets 2011 11 3 239 253 21247388
   PubMed Web of Science ®Google Scholar
• Maloney DG Grillo-Lopez AJ White CA IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma Blood 1997 90 6 2188 2195 9310469
   PubMed Web of Science ®Google Scholar
• Scott SD Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin’s lymphoma Cancer Pract 1998 6 3 195 197 9652253
   PubMedGoogle Scholar
• Milenic DE Brady ED Brechbiel MW Antibody-targeted radiation cancer therapy Nat Rev Drug Discov 2004 3 6 488 499 15173838
   PubMed Web of Science ®Google Scholar
• Dannenberg AJ Lippman SM Mann JR Subbaramaiah K DuBois RN Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention J Clin Oncol 2005 23 2 254 266 15637389
   PubMed Web of Science ®Google Scholar
• Taketo MM COX-2 and colon cancer Inflamm Res 1998 47 Suppl 2 S112 S116 9831333
   PubMed Web of Science ®Google Scholar
• Eberhart CE Coffey RJ Radhika A Giardiello FM Ferrenbach S DuBois RN Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 1994 107 4 1183 1188 7926468
   PubMed Web of Science ®Google Scholar
• Abdalla SI Lao-Sirieix P Novelli MR Lovat LB Sanderson IR Fitzgerald RC Gastrin-induced cyclooxygenase-2 expression in Barrett’s carcinogenesis Clin Cancer Res 2004 10 14 4784 4792 15269153
   PubMed Web of Science ®Google Scholar
• Dannenberg AJ Subbaramaiah K Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 2003 4 6 431 436 14706335
   PubMed Web of Science ®Google Scholar
• Fosslien E Molecular pathology of cyclooxygenase-2 in neoplasia Ann Clin Lab Sci 2000 30 1 3 21 10678579
   PubMed Web of Science ®Google Scholar
• Neufang G Furstenberger G Heidt M Marks F Muller-Decker K Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin Proc Natl Acad Sci U S A 2001 98 13 7629 7634 11381142
   PubMed Web of Science ®Google Scholar
• Liu CH Chang SH Narko K Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice J Biol Chem 2001 276 21 18563 18569 11278747
   PubMed Web of Science ®Google Scholar
• Oshima M Dinchuk JE Kargman SL Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 1996 87 5 803 809 8945508
   PubMed Web of Science ®Google Scholar
• Chulada PC Thompson MB Mahler JF Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Res 2000 60 17 4705 4708 10987272
   PubMed Web of Science ®Google Scholar
• Basu GD Pathangey LB Tinder TL Lagioia M Gendler SJ Mukherjee P Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer Mol Cancer Res 2004 2 11 632 642 15561779
   PubMed Web of Science ®Google Scholar
• Marnett LJ The COXIB experience: a look in the rearview mirror Annu Rev Pharmacol Toxicol 2009 49 265 290 18851701
   PubMed Web of Science ®Google Scholar
• Vane JR Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 1971 231 25 232 235 5284360
   PubMedGoogle Scholar
• Talley JJ Selective inhibitors of cyclooxygenase-2 (COX-2) Prog Med Chem 1999 36 201 234 10818674
   PubMed Web of Science ®Google Scholar
• Marnett LJ Kalgutkar AS Cyclooxygenase 2 inhibitors: discovery, selectivity and the future Trends Pharmacol Sci 1999 20 11 465 469 10542447
   PubMed Web of Science ®Google Scholar
• Kuge Y Katada Y Shimonaka S Synthesis and evaluation of radioiodinated cyclooxygenase-2 inhibitors as potential SPECT tracers for cyclooxygenase-2 expression Nucl Med Biol 2006 33 1 21 27 16459255
   PubMed Web of Science ®Google Scholar
• Zhang J Yu J Sun X Meng X Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer Cancer Lett 2014 351 1 6 12 24861428
   PubMed Web of Science ®Google Scholar
• Boyd M Mairs RJ Cunningham SH A gene therapy/targeted radiotherapy strategy for radiation cell kill by J Gene Med 2001 3 2 165 172 11318115
   PubMed Web of Science ®Google Scholar
• Boyd M Mairs RJ Keith WN An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects J Gene Med 2004 6 8 937 947 15293352
   PubMed Web of Science ®Google Scholar
• Boyd M Mairs SC Stevenson K Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy J Gene Med 2002 4 5 567 576 12221650
   PubMed Web of Science ®Google Scholar
• Cowen RL Williams KJ Chinje EC Hypoxia targeted gene therapy to increase the efficacy of tirapazamine as an adjuvant to radiotherapy: reversing tumor radioresistance and effecting cure Cancer Res 2004 64 4 1396 1402 14973055
   PubMed Web of Science ®Google Scholar
• Cunningham S Boyd M Brown MM A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma Med Pediatr Oncol 2000 35 6 708 711 11107152
   PubMedGoogle Scholar
• Fiveash JB Gillespie GY Oliver PG Zhou T Belenky ML Buchsbaum DJ Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5 Int J Radiat Oncol Biol Phys 2008 71 2 507 516 18474311
   PubMed Web of Science ®Google Scholar
• Fullerton NE Boyd M Mairs RJ Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate Prostate Cancer Prostatic Dis 2004 7 4 355 363 15477875
   PubMed Web of Science ®Google Scholar
• Fullerton NE Mairs RJ Kirk D Application of targeted radiotherapy/gene therapy to bladder cancer cell lines Eur Urol 2005 47 2 250 256 15661422
   PubMed Web of Science ®Google Scholar
• Trachtenberg J Weersink RA Davidson SR Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses BJU Int 2008 102 5 556 562 18494829
   PubMed Web of Science ®Google Scholar
• Weiss GJ Bunn PAJr Camidge DR From radiotherapy to targeted therapy: 20 years in the management of non-small-cell lung cancer Oncology (Williston Park) 2006 20 12 1515 1524 17153906
   PubMed Web of Science ®Google Scholar
• Willett CG Kozin SV Duda DG Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice Semin Oncol 2006 33 5 Suppl 10 S35 S40 17145523
   PubMed Web of Science ®Google Scholar
• Xu L Pirollo KF Chang EH Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy J Control Release 2001 74 1–3 115 128 11489488
   PubMed Web of Science ®Google Scholar
• Liu S Kurzrock R Toxicity of targeted therapy: implications for response and impact of genetic polymorphisms Cancer Treat Rev 2014 40 7 883 891 24867380
   PubMed Web of Science ®Google Scholar
• Merck and Co, Inc The Merck Veterinary Manual Whitehouse Station, NJ, USA 2012
   Google Scholar
• Weaver AD 15 cases of prostatic-carcinoma in the dog Vet Rec 1981 109 4 71 75 7292934
   PubMed Web of Science ®Google Scholar
• Hubbard BS Vulgamott JC Liska WD Prostatic adenocarcinoma in a cat J Am Vet Med Assoc 1990 197 11 1493 1494 2272882
   PubMed Web of Science ®Google Scholar